Pterin 6 aldehyde, a cancer cell catabolite: identification and application in diagnosis and treatment of human cancer

  • R. Halpern
  • , B. C. Halpern
  • , B. Stea
  • , A. Dunlap
  • , K. Conklin
  • , B. Clark
  • , H. Ashe
  • , L. Sperling
  • , J. A. Halpern
  • , D. Hardy
  • , R. A. Smith

Research output: Contribution to journalArticlepeer-review

61 Scopus citations

Abstract

Active folic degradation with the formation of pterin 6 aldehyde is a previously undescribed characteristic of cancer cells in tissue culture. Neither normal adult epithelial and fibroblastic cells nor human amniotic cells nor mouse embryonic fibroblasts degrade folic acid to a measurable degree. Twenty nine patients whose diagnoses were not revealed until after the test of their first morning urine for pterin 6 aldehyde was completed were studied for the presence or absence of pterin 6 aldehyde by thin layer chromatography. Pterin 6 aldehyde was found in the urine at about 300 nmol/ml or greater only in those 13 patients with a tissue diagnosis of cancer. When the cancer was totally resected, the pterin 6 aldehyde was no longer found in the urine postoperatively. Pterin 6 aldehyde is not found in the urine of healthy patients at this level of detection unless their diets are supplemented with folic acid.

Original languageEnglish (US)
Pages (from-to)587-591
Number of pages5
JournalProceedings of the National Academy of Sciences of the United States of America
Volume74
Issue number2
DOIs
StatePublished - 1977
Externally publishedYes

ASJC Scopus subject areas

  • General

Fingerprint

Dive into the research topics of 'Pterin 6 aldehyde, a cancer cell catabolite: identification and application in diagnosis and treatment of human cancer'. Together they form a unique fingerprint.

Cite this